Dataset Information


Bicomponent polymeric micelles for pH-controlled delivery of doxorubicin.

ABSTRACT: Stimuli-responsive drug delivery systems (DDSs) are expected to realize site-specific drug release and kill cancer cells selectively. In this study, a pH-responsive micelle was designed utilizing the pH-sensitivity of borate bonds formed between dopamine and boronic acid. First, methyl (polyethylene glycol)-block-polycaprolactone (mPEG-PCL) was conjugated with 4-cyano-4-(thiobenzoylthio)pentanoic acid (CTP) to obtain a macroinitiator. Two different segments poly(dopamine methacrylamide) (PDMA) and poly(vinylphenylboronic acid) (PVBA) were then grafted to the end of mPEG-PCL. Two triblock copolymers, mPEG-PCL-PDMA and mPEG-PCL-PVBA, were then obtained by reversible addition-fragmentation transfer (RAFT) polymerization. These copolymers and their mixture self-assembled in aqueous solution to form micelles that were able to load hydrophobic anticancer drug doxorubicin (DOX). These two-component micelles were found to be pH-sensitive, in contrast to the one-component micelles. Furthermore, MTT studies showed that the micelles were almost nontoxic. The DOX-loaded micelles showed cytotoxicity equivalent to that of DOX at high concentration. In vivo antitumor experiments showed that this pH-sensitive polymeric micellar system had an enhanced therapeutic effect on tumors. These two-component boronate-based pH micelles are universally applicable to the delivery of anticancer drugs, showing great potential for cancer therapy.


PROVIDER: S-EPMC7054969 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6404085 | BioStudies
2016-01-01 | S-EPMC6432143 | BioStudies
2017-01-01 | S-EPMC6418821 | BioStudies
2016-01-01 | S-EPMC6431869 | BioStudies
2019-01-01 | S-EPMC6523239 | BioStudies
1000-01-01 | S-EPMC6271086 | BioStudies
2018-01-01 | S-EPMC6096383 | BioStudies
1000-01-01 | S-EPMC4046072 | BioStudies
2020-01-01 | S-EPMC7504487 | BioStudies
2014-01-01 | S-EPMC4201986 | BioStudies